nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefalotin—SLC22A7—Fluorouracil—pancreatic cancer	0.31	0.342	CbGbCtD
Cefalotin—SLC22A7—Docetaxel—pancreatic cancer	0.237	0.261	CbGbCtD
Cefalotin—ALB—Erlotinib—pancreatic cancer	0.13	0.143	CbGbCtD
Cefalotin—ALB—Irinotecan—pancreatic cancer	0.117	0.129	CbGbCtD
Cefalotin—ALB—Fluorouracil—pancreatic cancer	0.112	0.124	CbGbCtD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—IFNA5—pancreatic cancer	0.00684	0.0729	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00562	0.0599	CbGpPWpGaD
Cefalotin—PTPN7—Ras signaling in the CD4+ TCR pathway—NRAS—pancreatic cancer	0.0045	0.048	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—ACVR1B—pancreatic cancer	0.00415	0.0442	CbGpPWpGaD
Cefalotin—PTPN7—Ras signaling in the CD4+ TCR pathway—KRAS—pancreatic cancer	0.00387	0.0413	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—IFNA1—pancreatic cancer	0.00375	0.04	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—DAXX—pancreatic cancer	0.0036	0.0384	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—IFNA2—pancreatic cancer	0.00349	0.0372	CbGpPWpGaD
Cefalotin—PTPN7—Ras signaling in the CD4+ TCR pathway—HRAS—pancreatic cancer	0.00329	0.0351	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00282	0.0301	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00224	0.0239	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—GADD45A—pancreatic cancer	0.00193	0.0206	CbGpPWpGaD
Cefalotin—ALB—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00183	0.0195	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—HSPA1A—pancreatic cancer	0.00182	0.0194	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—NRAS—pancreatic cancer	0.0013	0.0139	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.00127	0.0136	CbGpPWpGaD
Cefalotin—SLC22A11—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00119	0.0127	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—TNF—pancreatic cancer	0.00113	0.012	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—KRAS—pancreatic cancer	0.00112	0.0119	CbGpPWpGaD
Cefalotin—SLC15A2—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.0011	0.0117	CbGpPWpGaD
Cefalotin—SLC22A7—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00108	0.0115	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—EGF—pancreatic cancer	0.00103	0.011	CbGpPWpGaD
Cefalotin—SLC15A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00102	0.0109	CbGpPWpGaD
Cefalotin—SLC22A5—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.001	0.0107	CbGpPWpGaD
Cefalotin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000987	0.0105	CbGpPWpGaD
Cefalotin—ALB—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.000975	0.0104	CbGpPWpGaD
Cefalotin—PTPN7—Downstream signaling in naïve CD8+ T cells—HRAS—pancreatic cancer	0.000951	0.0101	CbGpPWpGaD
Cefalotin—SLC22A8—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000905	0.00966	CbGpPWpGaD
Cefalotin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000896	0.00955	CbGpPWpGaD
Cefalotin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000832	0.00888	CbGpPWpGaD
Cefalotin—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000756	0.00806	CbGpPWpGaD
Cefalotin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000753	0.00803	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00074	0.00789	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—CASP3—pancreatic cancer	0.000735	0.00784	CbGpPWpGaD
Cefalotin—ALB—HDL-mediated lipid transport—APOE—pancreatic cancer	0.00071	0.00757	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000684	0.00729	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000672	0.00716	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000635	0.00677	CbGpPWpGaD
Cefalotin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000628	0.0067	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000624	0.00666	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—NRAS—pancreatic cancer	0.000616	0.00657	CbGpPWpGaD
Cefalotin—ALB—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.000615	0.00656	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000603	0.00644	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—MYC—pancreatic cancer	0.000574	0.00612	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—TGFB1—pancreatic cancer	0.000572	0.0061	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000564	0.00602	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—EGFR—pancreatic cancer	0.000561	0.00599	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000557	0.00595	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000547	0.00584	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—TNF—pancreatic cancer	0.000534	0.0057	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—KRAS—pancreatic cancer	0.00053	0.00565	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000517	0.00552	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000509	0.00543	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—TP53—pancreatic cancer	0.000471	0.00503	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000471	0.00503	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00046	0.00491	CbGpPWpGaD
Cefalotin—SLC22A11—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000449	0.00478	CbGpPWpGaD
Cefalotin—SLC22A7—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000423	0.00451	CbGpPWpGaD
Cefalotin—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000414	0.00442	CbGpPWpGaD
Cefalotin—ALB—Lipoprotein metabolism—APOE—pancreatic cancer	0.000408	0.00435	CbGpPWpGaD
Cefalotin—SLC22A7—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000407	0.00434	CbGpPWpGaD
Cefalotin—PTPN7—MAPK Signaling Pathway—AKT1—pancreatic cancer	0.000398	0.00424	CbGpPWpGaD
Cefalotin—ALB—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000393	0.00419	CbGpPWpGaD
Cefalotin—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000385	0.0041	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000384	0.0041	CbGpPWpGaD
Cefalotin—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000378	0.00403	CbGpPWpGaD
Cefalotin—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000342	0.00365	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—SOD2—pancreatic cancer	0.000325	0.00347	CbGpPWpGaD
Cefalotin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—pancreatic cancer	0.000318	0.00339	CbGpPWpGaD
Cefalotin—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000285	0.00305	CbGpPWpGaD
Cefalotin—ALB—Lipid and lipoprotein metabolism—APOE—pancreatic cancer	0.000271	0.00289	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—APOE—pancreatic cancer	0.000267	0.00285	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—SOD2—pancreatic cancer	0.000265	0.00282	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000245	0.00261	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000228	0.00243	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000211	0.00225	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.00021	0.00224	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000207	0.00221	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0002	0.00213	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000195	0.00208	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000192	0.00205	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000174	0.00185	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—EGF—pancreatic cancer	0.000166	0.00177	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000158	0.00169	CbGpPWpGaD
Cefalotin—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000148	0.00158	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000145	0.00155	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.000123	0.00132	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IFNA5—pancreatic cancer	0.000119	0.00127	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000118	0.00126	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PPP2R5B—pancreatic cancer	0.000113	0.0012	CbGpPWpGaD
Cefalotin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000103	0.0011	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—VEGFA—pancreatic cancer	0.0001	0.00107	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—TNF—pancreatic cancer	0.0001	0.00107	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	9.57e-05	0.00102	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—TGFB1—pancreatic cancer	9.22e-05	0.000983	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—TP53—pancreatic cancer	8.85e-05	0.000944	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	8.78e-05	0.000937	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	7.98e-05	0.000851	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.54e-05	0.000804	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	7.45e-05	0.000795	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	7.36e-05	0.000785	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—CD44—pancreatic cancer	6.75e-05	0.00072	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	6.55e-05	0.000698	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IFNA1—pancreatic cancer	6.53e-05	0.000697	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PRSS1—pancreatic cancer	6.19e-05	0.000661	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IFNA2—pancreatic cancer	6.08e-05	0.000649	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	5.71e-05	0.000609	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ARG2—pancreatic cancer	5.37e-05	0.000573	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TYMP—pancreatic cancer	4.69e-05	0.000501	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	4.57e-05	0.000488	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	4.45e-05	0.000475	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PLAU—pancreatic cancer	4.32e-05	0.00046	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	4.09e-05	0.000436	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.87e-05	0.000413	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CG—pancreatic cancer	3.84e-05	0.00041	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—EGF—pancreatic cancer	3.8e-05	0.000405	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GLP1R—pancreatic cancer	3.78e-05	0.000404	CbGpPWpGaD
Cefalotin—ALB—Metabolism—DPYD—pancreatic cancer	3.72e-05	0.000397	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SLC2A2—pancreatic cancer	3.53e-05	0.000377	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.5e-05	0.000373	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	3.48e-05	0.000371	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CD—pancreatic cancer	3.38e-05	0.00036	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.37e-05	0.00036	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.07e-05	0.000328	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CB—pancreatic cancer	2.94e-05	0.000314	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	2.84e-05	0.000303	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CD44—pancreatic cancer	2.74e-05	0.000292	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.68e-05	0.000286	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.65e-05	0.000283	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GCG—pancreatic cancer	2.62e-05	0.00028	CbGpPWpGaD
Cefalotin—ALB—Metabolism—STK11—pancreatic cancer	2.47e-05	0.000263	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—SRC—pancreatic cancer	2.36e-05	0.000251	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.31e-05	0.000247	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—VEGFA—pancreatic cancer	2.3e-05	0.000245	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—NRAS—pancreatic cancer	2.27e-05	0.000242	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TYMS—pancreatic cancer	2.12e-05	0.000226	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—TGFB1—pancreatic cancer	2.11e-05	0.000225	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—KRAS—pancreatic cancer	1.95e-05	0.000208	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CA—pancreatic cancer	1.79e-05	0.000191	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—TP53—pancreatic cancer	1.73e-05	0.000185	CbGpPWpGaD
Cefalotin—ALB—Metabolism—APOE—pancreatic cancer	1.72e-05	0.000184	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—HRAS—pancreatic cancer	1.66e-05	0.000177	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.63e-05	0.000174	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CG—pancreatic cancer	1.56e-05	0.000166	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PPARG—pancreatic cancer	1.5e-05	0.00016	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—AKT1—pancreatic cancer	1.47e-05	0.000156	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CD—pancreatic cancer	1.37e-05	0.000146	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CB—pancreatic cancer	1.19e-05	0.000127	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PTGS2—pancreatic cancer	1.18e-05	0.000126	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PTEN—pancreatic cancer	1.03e-05	0.00011	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CA—pancreatic cancer	7.27e-06	7.76e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—AKT1—pancreatic cancer	5.94e-06	6.34e-05	CbGpPWpGaD
